Menopausal Hormone Therapy And Left Ventricular Function

NCT07242391 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2026-04-23

No results posted yet for this study

Summary

The purpose of this study is to compare left ventricular stroke volume and heart rate responses to bursts of SNA between PMF using, and not using, MHT.

Conditions

Interventions

DRUG

Menopausal Hormone Therapy

Taken in accordance with standard clinical practice, administered for a minimum duration of eight weeks.

Sponsors & Collaborators

Principal Investigators

  • Joshua Bock, Ph.D. · Mayo Clinic

Eligibility

Min Age
45 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-31
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07242391 on ClinicalTrials.gov